Mar­ket­ingRx roundup: Phar­ma ad­ver­tis­ers and March Mad­ness; No­vo lands near top of Fast Com­pa­ny's in­no­va­tion list

Phar­ma’s March Mad­ness ad play: The NCAA men’s col­lege bas­ket­ball play­off is al­ways rife with un­der­dogs, over­achiev­ers and mil­lions of fans. Phar­ma brands al­ready in play so far in­clude Bris­tol My­ers Squibb brands: pso­ri­a­sis med So­tyk­tu (16 air­ings) and im­muno-on­col­o­gy drug Op­di­vo (10 air­ings); plus, UCB’s new pso­ri­a­sis Bimzelx com­mer­cial (11 air­ings); BMS and As­traZeneca’s type 2 di­a­betes and CKD med Farx­i­ga (4 air­ings); and Astel­las’ menopause symp­tom treat­ment Veozah (2 air­ings), ac­cord­ing to re­al-time TV ad track­er iS­pot.tv.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.